Price Alert

Replimune Group Inc. (REPL)

NASDAQ: REPL · Real-Time Price · USD

4.53

-0.10 (-2.16%)

At close: Oct 10, 2025, 3:59 PM

4.54

0.22%

After-hours: Oct 10, 2025, 07:42 PM EDT

-2.16% (1D)

Bid	4.4
Market Cap	353.59M
Revenue (ttm)	1.47M
Net Income (ttm)	-280.22M
EPS (ttm)	-3.24
PE Ratio (ttm)	-1.4
Forward PE	-1.6
Analyst	Hold
Dividends	n/a

Ask	4.72
Volume	1,813,093
Avg. Volume (20D)	10,123,490
Open	4.66
Previous Close	4.63
Day's Range	4.50 - 4.73
52-Week Range	2.68 - 17.00
Beta	0.42
Ex-Dividend Date	n/a

About REPL

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol REPL

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for REPL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Replimune Group Inc. is scheduled to release its earnings on Nov 11, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

3 weeks ago

-39.4%

Replimune Group shares are trading lower as the co... Unlock content with Pro Subscription

2 months ago

+10.68%

Replimune shares are trading higher, reversing after falling on Monday.

News

2 weeks ago · zacks.com

REPL Stock Plunges 54% in 3 Months After FDA Rejects Skin Cancer Drug

Replimune stock dives 54% over three months after the FDA rejects its RP1/Opdivo melanoma drug filing, delaying its first potential product launch.

2 weeks ago · businesswire.com

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune

NEW YORK--(BUSINESS WIRE)---- $REPL #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Replimune Group, Inc. (“Replimune” or the “Com...

3 weeks ago · businesswire.com

REPL Deadline: Rosen Law Firm Encourages Replimune Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 22 Deadline in Securities Class Action First Filed by the Firm – REPL

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and July 21, 2025,...

3 weeks ago · fool.com

Why Replimune Stock Was Tumbling Again Today

One day after enduring a nearly 40% decline in its share price, bitoech Replimune (REPL -6.79%) was also down on Friday, although nowhere near as steeply. The company's stock was in the red by almost ...

1 month ago · businesswire.com

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune